Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-701-8 | CAS number: 798556-07-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Bacterial reverse mutation assay (Ames): negative; reference 7.6.1 -1
Chromosome aberration test in vitro: negative; reference 7.6.1 -2
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2011-09-13 to 2011-11-15
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- adopted 21 July 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- 30 May 2008
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- HIS operon (S. thyphimurium)
TRP operon (E. coli) - Species / strain / cell type:
- S. typhimurium TA 1535
- Details on mammalian cell type (if applicable):
- his G 46, uvrB, rfa
- Additional strain / cell type characteristics:
- other: mutations in the histidine operon
- Species / strain / cell type:
- S. typhimurium TA 1537
- Details on mammalian cell type (if applicable):
- his C 3076, uvrB, rfa
- Additional strain / cell type characteristics:
- other: mutations in the histidine operon
- Species / strain / cell type:
- S. typhimurium TA 98
- Details on mammalian cell type (if applicable):
- his D 3052, uvrB, rfa + R-factor
- Additional strain / cell type characteristics:
- other: mutations in the histidine operon
- Species / strain / cell type:
- S. typhimurium TA 100
- Details on mammalian cell type (if applicable):
- his G 46, uvrB, rfa + R-factor
- Additional strain / cell type characteristics:
- other: mutations in the histidine operon
- Species / strain / cell type:
- S. typhimurium TA 102
- Details on mammalian cell type (if applicable):
- his G 428, rfa + R-factor
- Additional strain / cell type characteristics:
- other: mutations in the histidine operon
- Species / strain / cell type:
- E. coli WP2
- Details on mammalian cell type (if applicable):
- his C 3076, uvrB, rfa
- Additional strain / cell type characteristics:
- other: mutations in the tryptophan operon
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver homogenate (S9 mix) with standard co-factors with metabolic activation (Aroclor)
- Test concentrations with justification for top dose:
- The test material concentrations were used selected according to the EC and OECD guidelines for this test system and the requirements of the Labor Ministry of Japan:
1. Series: 1.58, 5.00, 15.8, 50.0, 158, 500 and 1580 µg/plate
2. Series: 1.58, 2.81, 5.00, 15.8, 50.0 and 158 µg/plate - Vehicle / solvent:
- Acetone
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- sodium azide
- cumene hydroperoxide
- other: Daunomycin
- Remarks:
- without S9
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- other: 2-aminoanthracene
- Remarks:
- with S9
- Details on test system and experimental conditions:
- The assessment of test item-induced effects is dependent on the number of spontaneous revertants of each bacterial strain (solvent controls) and the increase in the number of revertants at the test item concentration which shows the highest number of colonies. The following criteria, based upon the historical controls of the laboratory and statistical considerations, are established:
-----------------------------------------------------------------------------------------
Mean Number of Colonies Maximal Mean Number of Colonies over the Actual
(Solvent Control) Solvent Control
(Test Material)
-----------------------------------------------------------------------------------------
<=10 <=9 >=30
<=30 <=19 >=40
<=80 <=29 >=80
<=200 <=49 >=120
<=500 <=79 >=200
Assessment No increase Clear increase
-----------------------------------------------------------------------------------------
All further results, ranging between "no" and "clear", are assessed as "weak in-creases". - Rationale for test conditions:
- According to the guideline.
- Evaluation criteria:
- A test material is defined as non-mutagenic in this assay if "no" or "weak increases" occur in the first and second series of the main experiment.
("Weak increases" randomly occur due to experimental variation.)
A test item is defined as mutagenic in this assay if:
- a dose-related (over at least two test material concentrations) increase in the number of revertants is induced, the maximal effect is a "clear increase", and the effects are reproduced at similar concentration levels in the same test system;
- "clear increases" occur at least at one test material concentration, higher concentrations show strong precipitation or cytotoxicity, and the effects are reproduced at the same concentration level in the same test system.
In all further cases, a third test series with the bacterial strain in question should be performed and the results of each series scould be discussed case by case. - Statistics:
- not required according to OECD TG 471
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Conclusions:
- With and without addition of S9 mix as the external metabolizing system, the test item was not mutagenic under the experimental conditions described.
- Executive summary:
The objective of this study was to provide information on possible health hazards for the test item and serve as a rational basis for risk assessment to the genotoxic potential of the test item in man.
The investigations for the mutagenic potential of the test item were performed using Salmonella typhimurium tester strains TA 98, TA 100, TA 102, TA 1535 and TA 1537, and Escherichia coil WP2 uvrA. The plate incorporation test with and without addition of liver S9 mix from Aroclor 1254-pretreated rats was used. Two independent experimental series were performed with TA 98, TA 100, TA 102,TA 1535 and TA 1537, and Escherichia coil WP2 uvr. In the two series with S9 mix, 10 or 30 % S9 in the S9 mix were used in the 1st and 2nd series, respectively. The test item was dissolved in acetone and tested at concentrations ranging from 1.58 to 1580 µg/plate.
Precipitation of the test item on the agar plates occurred at concentrations >=158 µg/plate. Toxicity to the bacteria was not observed. Daunomycin, sodium azide, 9-aminoacridine, 4 -nitroquinolin-N-oxide and cumene hydroperoxide served as strain specific positive control test materials in the absence of S9 mix. 2-Aminoanthracene and benzo[a]pyrene were used for testing the bacteria and the activity of the S9 mix. Each treatment with the test materials used as positive controls led to a clear increase in revertant colonies, thus, showing the expected reversion properties of all strains and good metabolic activity of the S9 mix used. In both series, each performed with and without the addition of rat liver S9 mix as the external metabolizing system, the test item showed no increase in the number of revertants of the bacterial strains TA 98, TA 100, TA 102, TA 1535 and TA 1537, and Escherichia coil WP2 uvr. According to the criteria for negative and positive results predetermined in the Study Protocol, the test item was not mutagenic under the experimental conditions described. With and without addition of S9 mix as the external metabolizing system, the test item was not mutagenic under the experimental conditions described.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2011-10-21 to 2012-04-19
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- adopted 21 July 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Version / remarks:
- 30 May 2008
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- CELLS USED
- Source of cells:Hoffmann-La Roche, Pharma, Basel, at May 27, 1997
The cells have a spontaneous aberration rate of about 0-5 % aberrant metaphases.
MEDIA USED
- Type and identity of media including CO2 concentration if applicable: The cells were cultured in DMEM supplemented with L-glutamine (4 mM), sodium bicarbonate (0.375 %), antibiotics (neomycine 0.015 %), and 10 % fetal calf serum (FCS). All incubations were performed at +37°C in a 4-5 % carbon dioxide atmosphere (100 % humidity). Before use, serum batches were screened for efffects on cloning efficiency and cell growth. - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix with S9 from Aroclor 1254 induced male rats
- Test concentrations with justification for top dose:
- Solubility experiments performed prior to the study start revealed the the test item was soluble in acetone at concenttrations <158 g/mL. Hence, the top concentration tested was limited by solubility.
The test item precipitated in the culture medium at concenrations above 88.9 µg/mL in the presence of S9 mix only (5 hours exposure time).
A change in the pH or the osmotic value of the cell culture medium did not occur in the dose range tested.
No clear cytotoxic effects, i.e. reduction in cell viability (MTT test) or mitotic index below 50% were induced by the test item.
For these reasons, cultures treated with the following test material concentrations were evaluated in absence and presence of S9 mix for the occurrence of chromosomal aberrations:
Experiment 1 (with and without S9 mix): 15.8, 50.0 and 158 µg/mL
Experiment 2 (without S9 mix): 15.8, 50.0 and 158 µg/mL - Vehicle / solvent:
- Acetone, 0.1% in the culture medium
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- other: Griseofulvin
- Remarks:
- - S9 mix
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- + S9 mix
- Details on test system and experimental conditions:
- A total of 100 metaphases were examined per culture for cytogenetic damage. Additionally, a total of 500 metaphases was examined per culture for the occurence of polyploidies.
Exposure times: -S9 mix: 5, 25 and 31 hours
+S9 mix. 5 hours
Solvent for the test material: Acetone
Positive controls: - S9 mix: 250 or 500 µg Ethylmethansulfonat (EMS)/mL
31.6 µg Griseofulvin (GRIS)/mL
+S9 mix: 2.00 µg Cyclophosphamide (CPA)/mL - Evaluation criteria:
- The decisive parameter for the evaluation of both, the treated and untreated cultures, is the number of aberrant metaphases (excluding gaps) per 100 cells. A basic prerequisite for the acceptance of a test series is (a) the correspondence of the actual negative controls with the historic negative controls of the laboratory and (b) a statistically significant and biologically relevant increase in the number of aberrant metaphases for the respective positive controls in relation to the actual negative controls. The discussion of biological relevance includes, among other things, considerations concerning the type and time dependent appearance of the observed chromosomal aberrations.
A test material is defined as being unambiguously negative or non-clastogenic in this test system if no statistically significant increase in the number of aberrant metaphases per 100 cells, as compared to the actual negative control, occurs at any test material concentration.
A test material is positive or clastogenic in this test system if
• a statistically significant, dose-related increase in the number of aberrant metaphases per 100 cells occurs or
• a statistically significant increase in the number of aberrant metaphases per 100 cells is reproduced at the same test material concentration in independent experiments.
In both cases, however, the number of aberrant metaphases should be above the range defined as the historical negative controls of the laboratory and the biological relevance of the results has to be discussed.
In all other cases, further decisions for testing strategies should be made following the scientific evaluation of all existing data including those of non toxicological investigations. - Statistics:
- Fisher’s Exact Test
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- True negative controls validity:
- not examined
- Positive controls validity:
- valid
- Conclusions:
- In conclusion, treatment of V79 cell cultures with the test item did not increase the proportion of cells with aberrant chromosomes in two independent experimental series in absence and presence of metabolic activation (S9 mix). The test material was not clastogenic in this in vitro test system.
- Executive summary:
The test material was investigated in two experimental series for induction of chromosomal aberrations in V79 Chinese hamster cells in vitro. This also included examinations on whether or not the test material may have the potential to induce numerical aberrations, i.e. an increase in endoreduplication or polyploidy.
The following experimental conditions were selected in the absence and presence of an exogenous metabolizing system (S9-mix from livers of rats pretreated with Aroclor 1254):
No. of slides per concentration:
Solvent control: 4
Others: 2
No. of metaphases evaluated per slide: 100 (for structural aberrations); 500 (for polyploidy)
Preparation times: 25 and 35 hours
Exposure times: -S9 mix: 25, and 31 hours
+S9 mix: 5 hours
Solvent for the test material: Acetone
Concentrations evaluated (+/- S9 mix):
Experiment 1: 15.8, 50.0 and 158 µg/mL
Experiment 2: 15.8, 50.0 and 158 µg/mL
Positive controls: - S9 mix: 500 / 250 µg Ethylmethansulfonat (EMS)/mL (1st / 2nd experiment)
31.6 µg Griseofulvin (GRIS)/mL
+S9 mix: 2.00 µg Cyclophosphamide (CPA)/mL
The mean values of aberrant metaphases (gaps excluded) in the negative controls of both experiments (in the absence and presence of S9 mix) ranged from 1.3 to 3.3 % and thus met the historical negative control range. The positive control test materials, EMS and CPA, induced the expected clear increase in the proportion of cells with chromosomal aberrations. Griseofulvin induced a clear increase in the number polyploid cells. Precipitation of the test item in the culture medium was only seen in the experimental part in the absence of S9 mix at concentraions > 88.9 µg/mL. No clear cytotoxic effects, i.e. reduction in mitotic index or cell viability (MTT-test) were induced by the test item. The limiting factor for the highest test concentration was the solubility of the test item. Treatment of V79 cells with the test item did not lead to a biologically relevant increase in the proportion of cells with aberrant chromosomes. Furthermore, no relevant treatment-related increase in endomitotic metaphases or polyploid cells was observed.
In conclusion, treatment of V79 cell cultures with the test item did not relevantly increase the proportion of cells with aberrant chromosomes in two independent experimental series in absence and presence of metabolic activation (S9 mix). The test item was not clastogenic in this in vitro test system.
Referenceopen allclose all
Please refer to the attached background document.
Please refer to the attached background material.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Bacterial reverse mutation assay, reference 7.6.1 -1
The objective of this study was to provide information on possible health hazards for the test item and serve as a rational basis for risk assessment to the genotoxic potential of the test item in man. The investigations for the mutagenic potential of the test item were performed using Salmonella typhimurium tester strains TA 98, TA 100, TA 102, TA 1535 and TA 1537, and Escherichia coil WP2 uvrA. The plate incorporation test with and without addition of liver S9 mix from Aroclor 1254-pretreated rats was used. Two independent experimental series were performed with TA 98, TA 100, TA 102,TA 1535 and TA 1537, and Escherichia coil WP2 uvr. In the two series with S9 mix, 10 or 30 % S9 in the S9 mix were used in the 1st and 2nd series, respectively. The test item was dissolved in acetone and tested at concentrations ranging from 1.58 to 1580 µg/plate. Precipitation of the test item on the agar plates occurred at concentrations >=158 µg/plate. Toxicity to the bacteria was not observed. Daunomycin, sodium azide, 9-aminoacridine, 4 -nitroquinolin-N-oxide and cumene hydroperoxide served as strain specific positive control test materials in the absence of S9 mix. 2-Aminoanthracene and benzo[a]pyrene were used for testing the bacteria and the activity of the S9 mix. Each treatment with the test materials used as positive controls led to a clear increase in revertant colonies, thus, showing the expected reversion properties of all strains and good metabolic activity of the S9 mix used. In both series, each performed with and without the addition of rat liver S9 mix as the external metabolizing system, the test item showed no increase in the number of revertants of the bacterial strains TA 98, TA 100, TA 102, TA 1535 and TA 1537, and Escherichia coil WP2 uvr. According to the criteria for negative and positive results predetermined in the Study Protocol, the test item was not mutagenic under the experimental conditions described. With and without addition of S9 mix as the external metabolizing system, the test item was not mutagenic under the experimental conditions described.
Chromosome Aberration assay in vitro, reference 7.6.1 -2
The test material was investigated in two experimental series for induction of chromosomal aberrations in V79 Chinese hamster cells in vitro. This also included examinations on whether or not the test material may have the potential to induce numerical aberrations, i.e. an increase in endoreduplication or polyploidy.
The following experimental conditions were selected in the absence and presence of an exogenous metabolizing system (S9-mix from livers of rats pretreated with Aroclor 1254):
No. of slides per concentration:
Solvent control: 4
Others: 2
No. of metaphases evaluated per slide: 100 (for structural aberrations); 500 (for polyploidy)
Preparation times: 25 and 35 hours
Exposure times: -S9 mix: 25, and 31 hours
+S9 mix: 5 hours
Solvent for the test material: Acetone
Concentrations evaluated (+/- S9 mix):
Experiment 1: 15.8, 50.0 and 158 µg/mL
Experiment 2: 15.8, 50.0 and 158 µg/mL
Positive controls: - S9 mix: 500 / 250 µg Ethylmethansulfonat (EMS)/mL (1st / 2nd experiment)
31.6 µg Griseofulvin (GRIS)/mL
+S9 mix:
2.00 µg Cyclophosphamide (CPA)/mL
The mean values of aberrant metaphases (gaps excluded) in the negative controls of both experiments (in the absence and presence of S9 mix) ranged from 1.3 to 3.3 % and thus met the historical negative control range. The positive control test materials, EMS and CPA, induced the expected clear increase in the proportion of cells with chromosomal aberrations. Griseofulvin induced a clear increase in the number polyploid cells. Precipitation of the test item in the culture medium was only seen in the experimental part in the absence of S9 mix at concentraions > 88.9 µg/mL. No clear cytotoxic effects, i.e. reduction in mitotic index or cell viability (MTT-test) were induced by the test item. The limiting factor for the highest test concentration was the solubility of the test item. Treatment of V79 cells with the test item did not lead to a biologically relevant increase in the proportion of cells with aberrant chromosomes. Furthermore, no relevant treatment-related increase in endomitotic metaphases or polyploid cells was observed.
In conclusion, treatment of V79 cell cultures with the test item did not relevantly increase the proportion of cells with aberrant chromosomes in two independent experimental series in absence and presence of metabolic activation (S9 mix). The test item was not clastogenic in this in vitro test system.
Justification for classification or non-classification
Classification, Labelling, and Packaging Regulation (EC) No 1272/2008
The available experimental test data is reliable and suitable for classification purposes under Regulation (EC) No 1272/2008. As a result the substance does not require classification as genotoxic under Regulation (EC) No 1272/2008, as amended for the twelfth time in Regulation (EU) No 2019/521.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.